Search

Showing "11154" results for ""

Stopping nevirapine five days prior to nucleosides may avoid resistance

Thai study finds primary fluconazole prophylaxis reduces death rate in AIDS patients

Symptoms versus laboratory monitoring as criteria for starting treatment

HIV-positive patients still at high risk of pneumococcal infections in the HAART era

Symptoms just as good as CD4 counts for identifying who needs treatment in South Africa

Canadian study warns that inability to access addiction treatment is associated with syringe sharing

Large number of young Canadian injecting drug users coinfected with HIV and HCV

Delaying HAART until CD4 counts are below 200 cells/mm3 results in poorer outcome

HCV coinfection does not hasten HIV disease progression finds pre-HAART study

Contraceptive choices of HIV-positive women are dependent on the partner’s HIV status

Atazanavir significantly reduces lipids 12 weeks after switching from nelfinavir

Genotype testing before treatment may identify patients susceptible to protease inhibitor resistance

Antibiotic prophylaxis fails to reduce HIV infection in Kenyan sex workers

Short-cycle intermittent HAART maintains undetectable viral load, but does not increase CD4 counts

UK study finds rapid HIV test safe, reliable, and cost effective

One in three HIV-positive gay men in London unaware they are infected

Record number of new UK HIV diagnoses made in 2003

HIV type 2 may not be well controlled by HAART regimens that work against HIV-1

Receive the latest HIV research and conference news

Showing "11154" results for ""

Stopping nevirapine five days prior to nucleosides may avoid resistance

Thai study finds primary fluconazole prophylaxis reduces death rate in AIDS patients

Symptoms versus laboratory monitoring as criteria for starting treatment

HIV-positive patients still at high risk of pneumococcal infections in the HAART era

Symptoms just as good as CD4 counts for identifying who needs treatment in South Africa

Canadian study warns that inability to access addiction treatment is associated with syringe sharing

Large number of young Canadian injecting drug users coinfected with HIV and HCV

Delaying HAART until CD4 counts are below 200 cells/mm3 results in poorer outcome

HCV coinfection does not hasten HIV disease progression finds pre-HAART study

Contraceptive choices of HIV-positive women are dependent on the partner’s HIV status

Atazanavir significantly reduces lipids 12 weeks after switching from nelfinavir

Genotype testing before treatment may identify patients susceptible to protease inhibitor resistance

Antibiotic prophylaxis fails to reduce HIV infection in Kenyan sex workers

Short-cycle intermittent HAART maintains undetectable viral load, but does not increase CD4 counts

UK study finds rapid HIV test safe, reliable, and cost effective

One in three HIV-positive gay men in London unaware they are infected

Record number of new UK HIV diagnoses made in 2003

HIV type 2 may not be well controlled by HAART regimens that work against HIV-1

Receive the latest HIV research and conference news